Healthcare
Panakes, Invitalia in €3m series-A for Aileens Pharma
Panakes principal Barbara Castellano and Invitalia’s Svetlana Vashkel will join the board
Sofinnova leads €4m seed round for Enthera
JDRF T1D Fund, managed by the Juvenile Diabetes Research Foundation, also takes part in the round
Compass completes portfolio acquisition from Bridgepoint
Deal sees Compass acquiring Bridgepoint's remaining interests in Rodenstock and Infinitas
Capital Croissance exits BioBank
Following the deal, Capital Croissance will reinvest in the company by acquiring a minority holding
SHS V holds first close on €90m
Vehicle was launched in March 2018 with a target of €150m, a 20% increase on SHS IV
The Carlyle Group buys LPG Systems
Europe and Asia-focused funds deployed to back France-based LPG, in view of Asian expansion
Abris acquires ITP
Company plans on expanding into the aesthetic medicine markets in China and the US
VC firms in $25m round for Polares Medical
Earlybird Venture Capital, Wellington Partners and Endeavour Vision also take part
VC firms sell Biosensia
Vendors include Act Venture Capital, Atlantic Bridge, Street Capital and Seroba Life Sciences
BPI France launches InnoBio 2
BPI France and France-based corporate Sanofi have already made commitments to the vehicle
Tesi co-leads €5m funding round for Oura
US-based Bold Capital Partners co-leads the deal and will introduce US industry specialists to the board
Forbion holds first close above target at €270m
Fund officially launched in May 2018 and Forbion expects to hold a final close in Autumn 2018
CVC in take-private deal for Hygeia
CVC Capital Partners is structuring the deal through special purpose vehicle Hellenic Healthcare
Abingworth closes 12th fund on $315m
ABV VII will follow the same strategy as its predecessor, investing in early- and late-stage deals
Andera et al. back Dynacure in €47m round
Investors support the biotech business in advancing its lead programme into clinical development
Auriga Partners leads €7m series-A for Nextbiotix
New funding will be used to support efforts in bringing new medicine to patients
NVM leads £2m round for Newcells Biotech
NVM provides ТЃ1.5m towards the round, while Northstar contributes the remaining ТЃ500,000
Weinberg's Pharma Omnium sells Biodim subsidiary
Apax Partners' NuPharm acquires France-based Laboratoire Biodim from its parent company
Nordic inks Prospitalia deal with Five Arrows
GP intends to support management in its plan to strengthen the company's market position
Waterland's Median buys Klinikzentrum Mühlengrund
Seventeenth bolt-on acquisition in the healthcare buy-and-build strategy since 2011
CVC buys 51.8% stake in Recordati for €3.03bn
Recordati family will receive €2.3bn in cash and €750m in subordinated long-term debt securities
Bain buys DSM Sinochem Pharmaceuticals
Bain Capital acquires DSM Sinochem Pharmaceuticals via its Bain Capital Europe IV vehicle
Novo Ventures leads CHF 20m round for NBE Therapeutics
PPF Capital Partners Fund and Boehringer Ingelheim Venture Fund (BIVF) also take part
Livingbridge sells Portman stake in SBO to Core Equity
GP sells its minority stake in the dentistry business after a four-year holding period